Analyst Ratings for Evoke Pharma (EVOK)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/22/2020 | H.C. Wainwright | Raghuram Selvaraju | Upgrade | Buy (Neutral) |
10.00 (N/A) |
2.35 (0.44) |
-81.28% | Details |
10/19/2017 | B.Riley » Updated 3/8/2018 |
N/A | New Coverage | Buy (N/A) |
5.00 (10.00) |
3.53 (0.44) |
-87.54% | Details |